Cash Flow Positive ELTP!!
More monster revenues coming!!!!!
Elite Pharmaceuticals last ten 10Q's:
2017 Q3 Loss from operations (1,722,423)
2018 Q1 Loss from operations (2,238,271)
2018 Q2 Loss from operations (2,129,871)
2018 Q3 Loss from operations (2,058,961)
2019 Q1 Loss from operations (1,858,394)
2019 Q2 Loss from operations (2,652,972)
2019 Q3 Loss from operations (2,637,130)
2020 Q1 Loss from operations (1,147,705)
2020 Q2 Loss from operations (454,532)
2020 Q3 Income from operations + 691,195
Quote:
1ST PROFITABLE QUARTER IN ELITES HISTORY! This is a milestone as it was achieved on operations.
